bpc-157 randomized controlled trial human BPC-157, There are currently no published trials (RCTs) of in humans. All existing evidence comes from preclinical animal studies, primarily in rodent models., The bpc 157 human clinical trials

It isn't hepatotoxic or nephrotoxic

If you have spent any time researching BPC-157 online, you have seen lists of claimed benefits that range from tendon healing to neuroprotection to anti-aging

1 This is especially true in high-stress areas like the Achilles, quadriceps tendon, and medial collateral ligament (MCL)

This method delivers the peptide locally to follicles while injectable protocols provide systemic support

Reporting side effects: If you experience a suspected side effect from any medicine including within a clinical trial you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app